📰 Japan’s Ministry of Health, Labor and Welfare has approved subcutaneous pembrolizumab across all indications for which IV pembrolizumab is approved in Japan. #oncology
Full story ➡️: www.onclive.com/view/japan-a...
@onclive.bsky.social
@onclive.bsky.social📰 Japan’s Ministry of Health, Labor and Welfare has approved subcutaneous pembrolizumab across all indications for which IV pembrolizumab is approved in Japan. #oncology
Full story ➡️: www.onclive.com/view/japan-a...
@eortc.org🚨 Just 9 days left to register at the Regular Rate for #ENASymp26!
Register by 30 September: https://ow.ly/Bn4150ZPI9J
📅 18–20 November 2026
📍 Barcelona, Spain
American Association for Cancer Research (AACR) The National Cancer Institute
#CancerResearch #Oncology
@protocolandpeople.bsky.social🎯What does stage mean?
Stage describes how far cancer has spread from where it started.
Cancer stage is set and diagnosis & does not change when treatment works. Two people with the same stage can do very differently.
@onclive.bsky.socialReady for The Five Under 5 🕘? Here is your go-to roundup of the top 5 #OncLiveTV 📹 videos of last week. @danafarber.bsky.social @mdanderson.bsky.social @ucdavis.bsky.social #hematology #oncology
Watch the clips that made the list 🔗: www.onclive.com/view/five-un...
@bio-integration.orgVHHNectin4 #CART cells are engineered for precision.
They expand CD4+ & memory T cells, secrete cytokines & kill Nectin4+ #BladderCancer cells without affecting Nectin4 negative cells, supporting translational promise. #medsky #Oncology
#BIOI #OpenAccess: doi.org/10.15212/bio...
@bcc2026.bsky.social🎗️ Breast Cancer Congress 2027
Join researchers, clinicians, surgeons and healthcare professionals for discussions on advances in breast cancer research, treatment and patient care.
June 17–18, 2027
Zurich, Switzerland
@biotechstockdaily.bsky.socialPhase 3 REZILIENT3 data: zipalertinib plus chemotherapy significantly extended progression-free survival in first-line EGFR exon 20 insertion-positive NSCLC.
#Biotech #Biotechnology #Oncology
Disclaimer: This is NOT a financial advice.
@biotechstockdaily.bsky.socialPhase III trial data shows Tam-Peli, a B7-H3-targeted antibody-drug conjugate licensed to Roche, significantly improved survival versus topotecan in relapsed small-cell lung cancer.
#Oncology #LungCancer #Biotech
Disclaimer: This is NOT a financial advice
@arcportal.org.au📅 Mark your calendars! From clinical symposiums to advocacy forums and scientific meetings, there's a lot happening over the coming months for the rare cancer community, clinicians and researchers alike.
@cancers-mdpi.bsky.social👏Thrilled to share our highly-cited #SpecialIssues in 2025 Related to Cancer #Biomarkers!
Explore here🔎 www.mdpi.com/about/announ...
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVYrKq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@martraduce.bsky.social#Oncology has been advancing so much this last few years :-). Personalized treatments, mRNA vaccines for some types of cancer.
Awesome scientists researching to make people's lives better deserve everything good that comes their way.
Thank you for sharing the news :-)
@sip-com-acpe.bsky.socialTitle: Common antidepressant boosts engineered virus treatment for brain cancer in mice
Link: ift.tt/KhgQTjC
#psychiatry #neuroimmunology #glioblastoma #spirituallyIntegratedPsychotherapy #oncology
@samillingworth.com🩸 Bladder cancer keeps seeding itself
Fred Hutchinson researchers in the US traced how patients' bladder cancers spread. It mostly spreads between secondary tumours, and more varied migrating cells meant a worse outlook for patients.
@meducationai.bsky.socialMed school teaches you medicine. Fellowship teaches you cancer. Who keeps you current after that? OncoPulse is a free AI agent that emails you new evidence in the cancers you treat.
@onclive.bsky.social📺 In this episode of The Moonlight Shift, Jyoti Malhotra, MD, discusses first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to @yalecancer.bsky.social. #lcsm #oncology
Watch now ➡️: www.onclive.com/view/first-i...
@onclive.bsky.socialWATCH: Lucy Gilbert, MD, MSc, FRCOG, discusses data from the ROSELLA trial of relacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer. @ascocancer.bsky.social #ASCO26 #gyncsm #oncology
Full video ➡️: www.onclive.com/view/dr-gilb...
@onclive.bsky.social🇪🇺 The CHMP has has recommended EU marketing authorization for senaparib as a first-line maintenance treatment for advanced ovarian cancer, based on the phase 3 FLAMES trial.
Read more here 📈: www.onclive.com/view/eu-appr...
@nikolospharma.bsky.social